EMPLOYMENT AGREEMENT (Change of Control)Employment Agreement • March 13th, 2009 • Noven Pharmaceuticals Inc • Pharmaceutical preparations • Florida
This Employment Agreement (“Agreement”), dated as of is entered into between Noven Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Executive”).
November 5, 2008Termination Agreement • March 13th, 2009 • Noven Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Reference is made to (1) the Letter Agreement dated as of June 15, 2004, by and between Noven Pharmaceuticals, Inc. (“Noven”) and Shire US Inc. (“Shire US”), relating to the Development of the Amphetamine Transdermal Delivery System (the “2004 Agreement”), which agreement was assigned by Shire US to, and assumed by, its affiliate Shire Pharmaceuticals Ireland Limited (“Shire Ireland” and, collectively with Shire US, “Shire”); (2) the Letter Agreement dated as of May 4, 2007, by and between Noven and Shire Ireland, which supplemented and amended the 2004 Agreement (the “2007 Agreement”); and (3) the Letter Agreement dated as of June 4, 2007, by and between Noven and Shire Ireland, which further amended the 2004 Agreement, and pursuant to which Shire Ireland exercised its “Buy-Back Right” granted under the 2007 Agreement (the “Buy-Back Agreement”). The 2004 Agreement, the 2007 Agreement and the Buy-Back Agreement are referred to herein collectively as the “ATS Agreements.”
AMENDMENT TO DEVELOPMENT, LICENSE AND SUPPLY AGREEMENTDevelopment, License and Supply Agreement • March 13th, 2009 • Noven Pharmaceuticals Inc • Pharmaceutical preparations
THIS AMENDMENT TO THE DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT (the “Amendment”) is entered into as of the 23rd day of December 2008, by and between Banner Pharmacaps Inc., a Delaware corporation (“Banner”), and Noven Therapeutics, LLC, (f/k/a JDS Pharmaceuticals, LLC, (“Noven”), a Delaware limited liability corporation.
